hesperidin has been researched along with raltegravir potassium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rahman, IM; Abdelhamid, MM; Abdelwahab, SF; Abu-Hussein, B; Al-Khdhairawi, A; Alqaisi, AM; El-Sheikh, AAK; Hassan, HA; Mohamed, EAR; Rahim, LBA; Zaki, MEA | 1 |
1 other study(ies) available for hesperidin and raltegravir potassium
| Article | Year |
|---|---|
In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing.
Topics: COVID-19; Drug Repositioning; Hesperidin; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Raltegravir Potassium; SARS-CoV-2 | 2023 |